Pembrolizumab (pembro) 1 chemotherapy (chemo) in metastatic squamous NSCLC: Final analysis and progression after the next line of therapy (PFS2) in KEYNOTE-407

dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authoridSOTO PARRA, HECTOR J/0000-0001-7966-4472
dc.authoridSOTO PARRA, HECTOR J/0000-0001-7966-4472
dc.authorwosidPaz-Ares, Luis/AAH-2750-2019
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.authorwosidSOTO PARRA, HECTOR J/ABC-6273-2021
dc.authorwosidSOTO PARRA, HECTOR J/IZE-2180-2023
dc.contributor.authorPaz-Ares, L.
dc.contributor.authorVicente, D.
dc.contributor.authorTafreshi, A.
dc.contributor.authorRobinson, A.
dc.contributor.authorSoto Parra, H.
dc.contributor.authorMazieres, J.
dc.contributor.authorHermes, B.
dc.date.accessioned2024-06-12T11:24:06Z
dc.date.available2024-06-12T11:24:06Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description44th Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 27-OCT 01, 2019 -- Barcelona, SPAINen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncol,Japanese Soc Med Oncolen_US
dc.description.sponsorshipMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USAen_US
dc.description.sponsorshipMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26799
dc.identifier.volume30en_US
dc.identifier.wosWOS:000491295500206en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titlePembrolizumab (pembro) 1 chemotherapy (chemo) in metastatic squamous NSCLC: Final analysis and progression after the next line of therapy (PFS2) in KEYNOTE-407en_US
dc.typeConference Objecten_US

Dosyalar